We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take place … more →
24/7 Wall St.wrote 3 days ago: Notice the rabbit-proof fence in the upper right. We have a bald female cardinal in the yard. The fi … more →
wrote 2 weeks ago: We are now just about two weeks away from the king of biotech and pharma events in cancer treatments … more →
wrote 3 weeks ago: It is now getting close to the middle of May, and that means one thing for biotech investors. The k … more →
wrote 1 month ago: Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help … more →
wrote 2 months ago: If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuti … more →
wrote 2 months ago: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on th … more →
wrote 2 months ago: Dendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a … more →
wrote 2 months ago: By now, most investors know that the large hedge funds are run by billionaires rather than millionai … more →
wrote 3 months ago: Indian drug maker Sun Pharmaceutical Industries Ltd. has received approval from the US Food and Drug … more →
wrote 4 months ago: All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI … more →
wrote 4 months ago: Drug maker Eli Lilly & Co. reported fourth quarter and full year earnings this morning, and alth … more →
wrote 4 months ago: Profits at Eli Lilly & Co. (NYSE: LLY) in 2012 will be sharply lower than analysts had been expe … more →
wrote 6 months ago: We wrap up an interesting week with thanks to all the veterans for their dedication and service. No … more →
wrote 6 months ago: Greece will announce its new government today. (Reuters) Inflation in China drops in October. (Reute … more →
wrote 7 months ago: Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the com … more →
wrote 8 months ago: Insiderslab.com has issued insider trading reports and Equity Research for the following companies: … more →
wrote 9 months ago: Insiderslab.com has issued insider trading reports and Equity Research for the following companies: … more →
wrote 10 months ago: Ok, who am I kidding, a watchlist? Come on. This was one of those transcendental kind of … more →
wrote 10 months ago: Once patent protection expires on a prescription drug, the drug’s maker can take a serious bea … more →